Baird Financial Group’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-33,338
| Closed | -$963K | – | 1768 |
|
|
2022
Q2 | $963K | Sell |
33,338
-8,041
| -19% | -$232K | ﹤0.01% | 1095 |
|
|
2022
Q1 | $1.43M | Sell |
41,379
-8,849
| -18% | -$305K | ﹤0.01% | 1009 |
|
|
2021
Q4 | $2.2M | Buy |
50,228
+1,355
| +3% | +$59.3K | 0.01% | 898 |
|
|
2021
Q3 | $2.48M | Buy |
48,873
+1,772
| +4% | +$89.8K | 0.01% | 863 |
|
|
2021
Q2 | $2.45M | Buy |
47,101
+3,147
| +7% | +$164K | 0.01% | 830 |
|
|
2021
Q1 | $2.01M | Buy |
+43,954
| New | +$2.01M | 0.01% | 881 |
|